TOTH FINANCIAL ADVISORY CORP

Position in EYPT — EyePoint, Inc.

CIK 866780 LEESBURG, VA

Position in EYPT

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$25,792

-$10,766 QoQ

Shares Held

2,001

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TOTH FINANCIAL ADVISORY CORP holds $6,027,293 across 24 Biotechnology names. EYPT ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	13,695	$1,288,973
2	JAZZ	Jazz Pharmaceuticals plc	6,600	$1,247,730
3	ASND	Ascendis Pharma A/S	5,450	$1,246,578
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,000	$1,046,940
5	RYTM	Rhythm Pharmaceuticals, Inc.	10,000	$869,700
6	VRTX	Vertex Pharmaceuticals Inc / Ma	306	$136,641
7	ARGX	Argenx SE	145	$105,886
8	EYPT	EyePoint, Inc. This page	2,001	$25,792

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,792	2,001	0.0%	Shares	Sole	2026-04-16
2025-12-31	$36,558	2,001	0.0%	Shares	Sole	2026-01-20
2025-09-30	$28,494	2,001	0.0%	Shares	Sole	2025-10-09
2025-06-30	$18,829	2,001	0.0%	Shares	Sole	2025-07-14
2025-03-31	$10,845	2,001	+99.9%	Shares	Sole	2025-04-14
2024-12-31	$7,457	1,001	0.0%	Shares	Sole	2025-01-21
2024-09-30	$7,997	1,001	-80.0%	Shares	Sole	2024-10-21
2024-03-31	$103,350	5,000	0.0%	Shares	Sole	2024-04-16
2023-12-31	$115,550	5,000	+42.9%	Shares	Sole	2024-01-26
2023-09-30	$27,965	3,500	+250.0%	Shares	Sole	2023-10-12
2023-06-30	$8,700	1,000	—	Shares	Sole	2023-07-24
No filing history on record for this holder in this stock.